Stocks
Moderna (MRNA) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 032% | 701.1% | 823.8% | 823.8% | 685.3% | 646.7% | |||
| Changes by years, y/y, % | +459pp | -1 331pp | +123pp | 0pp | -138pp | +9.8% | |||
Moderna. R&D/CAPEX, %
Moderna. R&D/CAPEX, changes, pp
Moderna (MRNA) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 828.6% | 639.1% | 524.0% | 648.4% | 646.7% | |||
| Changes by years, y/y, % | -921pp | -93pp | -677pp | -477pp | +158pp | |||
| Changes by quarters, q/q, % | -491pp | -189pp | -115pp | +124pp | ||||
